Integrated Pain Management, Inc. First in Bay Area and Northern California To Implant HF10 Therapy for the Superior Treatment of Low Back and Leg Pain

WALNUT CREEK, Calif., July 28, 2015 /PRNewswire/ -- Integrated Pain Management, Inc. is pleased to announce the first commercial implantation of the Senza^® HF10 spinal cord stimulator device (Nevro Corporation, Menlo Park, CA) in the Bay Area and Northern California. The Senza^® HF10 therapy is a recently FDA approved spinal cord stimulator that has been shown to have superior results for the treatment of back and leg pain in a large multi-center study in the United States.

"I'm honored to be the first pain physician in Northern California to offer this promising technology to patients with chronic low back and leg pain," said Kas Amirdelfan, M.D., Medical Director at IPM in Walnut Creek, California. "As a principal investigator in the study, which led to the approval of the Senza^® device in the United States, I had a firsthand experience with the level of pain relief this therapy has provided our patients, over the past two years. I'm confident we will able to provide similar superior results for other patients with chronic back and leg pain who would be appropriate candidates for this technology."

Chronic low back and leg pain continue to be one of the most common complaints among pain patients. Moderate to severe chronic pain in the lower back and legs has been shown to have a significant negative impact on the patients' function and quality of life. The treatment for low back and leg pain, thus far, has included exercise and physical therapy, epidural injections, medications or implantable technology. Physical therapy and exercise can be difficult for patients with moderate to severe pain, epidural injections may only provide short-lived improvement of the pain and medications have associated grave side effects and social stigma, including physical dependency and constipation.

Spinal cord stimulation has been available since the 1970's. However, recent advances in this technology has provided patient improved low back pain and leg pain relief. With the recent FDA approval of Senza^® HF10 therapy, physicians may be able to provide appropriate patients with superior back and leg pain control. Traditional spinal cord stimulation (SCS) delivers small electrical pulses that attempt to mask pain with a tingling or buzzing sensation called paresthesia. Senza^® HF10 uses a proprietary, high-frequency waveform that allows a method of relieving pain without paresthesia. This key difference allows the Senza^® system to be used for pain control during sleep or while driving.

About Integrated Pain Management: IPM Medical Group, Inc. is a large interventional pain management group headquartered in Walnut Creek, with satellite offices in Brentwood, Oakland, Alameda and Livermore. IPM also has a robust research division, engaging in patient oriented pain research, in order to provide the patients at IPM with cutting edge treatment modalities. For more information, please refer to the IPM's website WWW.IPMDOCTORS.COM or contact Dr. Amirdelfan at 925-482-8116.

Photo - http://photos.prnewswire.com/prnh/20150728/247416
Logo - http://photos.prnewswire.com/prnh/20150728/247533LOGO

SOURCE Integrated Pain Management, Inc.

Related Links

http://www.ipmdoctors.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED